Boston, MA -- (SBWIRE) -- 09/16/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (Enanta Pharmaceuticals Inc (NASDAQ:ENTA), Vitamin Shoppe Inc (NYSE:VSI), Sibanye Gold Ltd (ADR) (NYSE:SBGL), Merrimack Pharmaceuticals Inc (NASDAQ:MACK)
Enanta Pharmaceuticals Inc (NASDAQ:ENTA) shares decreased 2.65% to $19.09. The company on Sept. 3 announced that the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), has agreed to provide additional funding of $9.2 million to its existing contract with Enanta to fund preclinical and early clinical development for a new class of bridged bicyclic antibiotics known as Bicyclolides. NIAID is funding development of the Bicyclolides for use as medical countermeasures against multiple biodefense Category A and B bacteria. This brings total funding from NIAID to date to approximately $23.5 million. As part of a multi-year contract that was awarded in 2011, this funding could total approximately $42.7 million if all project milestones are met and NIAID exercises all its options to fund additional development under the contract.
Is ENTA A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Vitamin Shoppe Inc (NYSE:VSI) shares decreased 2.62% and closed at $40.86. Sterne Agee analyst cut his rating for the stock to "Neutral" from "Buy," citing a recent slowdown in its website traffic and sales on Sept. 13.
Charles Grom, who also cut his price target to $45 from $54, noted that the company's revenue at stores open at least a year have slowed considerably. He said that its 2.3 percent increase in the second quarter of this year was down from a 4.5 percent increase in the first quarter and 5.2 percent growth in the fourth quarter of 2012.
Is VSI A Good Buy After The Recent Price Movement? Find Out Here
Sibanye Gold Ltd (ADR) (NYSE:SBGL) stock declined 2.60% to $4.50. The company is a producer of gold in South Africa. Sibanye Gold is primarily engaged in underground and surface gold mining and related activities, including extraction, and processing. Sibanye Gold’s operations are located in South Africa. Its principal mining operations include Kloof-Driefontein Complex (KDC) and Beatrix.
How Should Investors Trade SBGL After The Recent Volatility? Get Free Report Here
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) shares declined 2.52% to $3.87. The company on August 28 announced that the enrollment goal has been reached in the NAPOLI-1 trial. NAPOLI-1 is a randomized Phase 3 study of MM-398, with or without 5-fluorouracil (5-FU) and leucovorin (LV), versus 5-FU and LV, in patients with metastatic pancreatic cancer previously treated with gemcitabine-based therapy.
Currently, there is no approved treatment for patients with metastatic pancreatic cancer after gemcitabine has failed, nor is there a clear consensus on the standard of care in this patient group.
How Should Investors Trade MACK After The Recent Volatility? Get Free Report Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)